Marina Cools

724 total citations
17 papers, 617 citations indexed

About

Marina Cools is a scholar working on Epidemiology, Genetics and Molecular Biology. According to data from OpenAlex, Marina Cools has authored 17 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Marina Cools's work include Virus-based gene therapy research (9 papers), Herpesvirus Infections and Treatments (6 papers) and Respiratory viral infections research (3 papers). Marina Cools is often cited by papers focused on Virus-based gene therapy research (9 papers), Herpesvirus Infections and Treatments (6 papers) and Respiratory viral infections research (3 papers). Marina Cools collaborates with scholars based in Belgium and United States. Marina Cools's co-authors include Erik De Clercq, Robert Snoeck, Graciela Andreï, R. T. BORCHARDT, Jan Balzarini, Jan Balzarini, Mitsuaki Hosoya, Shirô Shigeta, Noriaki Minakawa and David R. Borcherding and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Antimicrobial Agents and Chemotherapy and British Journal of Cancer.

In The Last Decade

Marina Cools

17 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marina Cools Belgium 14 273 253 204 93 70 17 617
Aleš Merta Czechia 10 225 0.8× 227 0.9× 249 1.2× 81 0.9× 62 0.9× 15 479
Gussie Arnett United States 12 255 0.9× 174 0.7× 192 0.9× 165 1.8× 61 0.9× 20 507
K Konno Japan 11 144 0.5× 387 1.5× 190 0.9× 79 0.8× 66 0.9× 23 591
Andrzej Piasek Poland 12 369 1.4× 161 0.6× 104 0.5× 183 2.0× 24 0.3× 23 785
John Wickersham United States 8 314 1.2× 216 0.9× 126 0.6× 42 0.5× 78 1.1× 10 724
Mireille Cartier Canada 13 485 1.8× 229 0.9× 114 0.6× 40 0.4× 38 0.5× 17 826
Jan Olof Noren Sweden 6 167 0.6× 231 0.9× 164 0.8× 90 1.0× 39 0.6× 8 474
Muriel Lavie France 16 202 0.7× 285 1.1× 92 0.5× 30 0.3× 73 1.0× 23 769
S. Shane Taremi United States 11 250 0.9× 217 0.9× 159 0.8× 17 0.2× 68 1.0× 14 712
W L Kennell United States 9 158 0.6× 282 1.1× 138 0.7× 100 1.1× 48 0.7× 11 497

Countries citing papers authored by Marina Cools

Since Specialization
Citations

This map shows the geographic impact of Marina Cools's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Cools with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Cools more than expected).

Fields of papers citing papers by Marina Cools

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Cools. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Cools. The network helps show where Marina Cools may publish in the future.

Co-authorship network of co-authors of Marina Cools

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Cools. A scholar is included among the top collaborators of Marina Cools based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Cools. Marina Cools is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Doyon, Julien, et al.. (2004). 2-Mercaptoimidazoles, a new class of potent CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 497–500. 30 indexed citations
2.
Andrés, José Ignacio, José Manuel Alonso Segura, Javier Fernández, et al.. (2002). Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(4). 653–658. 21 indexed citations
3.
Neefs, Jean‐Marc, et al.. (2000). Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation. British Journal of Cancer. 82(6). 1123–1130. 66 indexed citations
4.
Wauwe, J. Van, F. Aerts, Marina Cools, et al.. (2000). Identification of R146225 as a Novel, Orally Active Inhibitor of Interleukin-5 Biosynthesis. Journal of Pharmacology and Experimental Therapeutics. 295(2). 655–661. 17 indexed citations
5.
Snoeck, Robert, Graciela Andreï, Johan Neyts, et al.. (1993). Inhibitory activity of S-adenosylhomocysteine hydrolase inhibitors against human cytomegalovirus replication. Antiviral Research. 21(3). 197–216. 32 indexed citations
6.
Cools, Marina, F. Aerts, & J. Van Wauwe. (1992). Lack of immunosuppression by ketoconazole and itraconazole. International Journal of Immunopharmacology. 14(6). 1011–1017. 5 indexed citations
7.
Cools, Marina, Jan Balzarini, & Erik De Clercq. (1991). Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase.. Molecular Pharmacology. 39(6). 718–724. 15 indexed citations
8.
Clercq, Erik De, Marina Cools, Jan Balzarini, et al.. (1991). Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds. Antimicrobial Agents and Chemotherapy. 35(4). 679–684. 111 indexed citations
9.
Cools, Marina & Erik De Clercq. (1990). Influence of S-adenosylhomocysteine hydrolase inhibitors on S-adenosylhomocysteine and S-adenosylmethionine pool levels in L929 cells. Biochemical Pharmacology. 40(10). 2259–2264. 29 indexed citations
10.
Cools, Marina, Masahide Hasobe, Erik De Clercq, & Ronald T. Borchardt. (1990). Mechanism of the synergistic antiviral and cytostatic activity of (RS)-3-(adenin-9-YL)-2-hydroxypropanoic acid isobutyl ester and d,l-homocysteine. Biochemical Pharmacology. 39(1). 195–202. 12 indexed citations
11.
Clercq, Erik De, Marina Cools, & Jan Balzarini. (1989). Homocysteine potentiates the antiviral and cytostatic activity of those nucleoside analogues that are targeted at S-adenosylhomocysteine hydrolase. Biochemical Pharmacology. 38(11). 1771–1778. 17 indexed citations
12.
Aerschot, Arthur Van, Piet Herdewijn, G. Janssen, Marina Cools, & Erik De Clercq. (1989). Synthesis and antiviral activity evaluation of 3′-fluoro-3′-deoxyribonucleosides: broad-spectrum antiviral activity of 3′-fluoro-3′-deoxyadenosine. Antiviral Research. 12(3). 133–150. 30 indexed citations
15.
Clercq, Erik De, Marina Cools, Jan Balzarini, et al.. (1989). Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5'-nor derivatives. Antimicrobial Agents and Chemotherapy. 33(8). 1291–1297. 97 indexed citations
16.
Cools, Marina, Erik De Clercq, & John C. Drach. (1987). Role of Adenosine Kinase in the Biological (Antiviral and Anticellular) Activities of Adenosine Analogues. Nucleosides and Nucleotides. 6(1-2). 423–424. 2 indexed citations
17.
Clercq, Erik De & Marina Cools. (1985). Antiviral potency of adenosine analogues: Correlation with inhibition of S-adenosylhomocysteine hydrolase. Biochemical and Biophysical Research Communications. 129(1). 306–311. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026